George Yancopoulos, EVP CSO President Regeneron Re at REGENERON PHARMACEUTICALS INC (REGN), sold 33,150 shares at $120.21 ($4.0M) on 2012-03-26, disclosed to the SEC on 2012-03-27.
Scheduled sale ($4.0M) by EVP CSO President Regeneron Re under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.21 | 32,140 | $3.9M | 96.9% |
| 2 | $121.09 | 1,010 | $122K | 3.1% |
| Total | $120.24 avg | 33,150 | $4.0M | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |